Alnylam Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Alnylam Pharmaceuticals patents 40 in total
| Status | Patent |
|---|---|
Application | Utility: METHODS FOR TREATING OR PREVENTING CONTACT-ACTIVATION PATHWAY-ASSOCIATED DISEASES USING iRNA COMPOSITIONS TARGETING FACTOR XII (HAGEMAN FACTOR) (F12) Filling date: 26 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: REVERSIR TM COMPOUNDS Filling date: 26 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE Filling date: 26 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: Methods of Treating Transthyretin (TTR) Mediated Amyloidosis Filling date: 26 Sep 2025 Issue date: 11 Aug 2022 |
Grant | Utility: Modified RNAi agents Filling date: 26 Sep 2025 Issue date: 9 Aug 2022 |
Application | Utility: LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF SERUM AMYLOID A GENE Filling date: 26 Sep 2025 Issue date: 4 Aug 2022 |
Grant | Utility: Biodegradable lipids for the delivery of active agents Filling date: 26 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Modified double-stranded RNA agents Filling date: 26 Sep 2025 Issue date: 2 Aug 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: Carboxypeptidase B2 (CPB2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 21 Jul 2022 |
Grant | Utility: Biodegradable lipids for the delivery of active agents Filling date: 26 Sep 2025 Issue date: 12 Jul 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE Filling date: 26 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 26 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: POLYNUCLEOTIDE AGENTS TARGETING COMPLEMENT COMPONENT C5 AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT Filling date: 26 Sep 2025 Issue date: 19 May 2022 |
Grant | Utility: Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Filling date: 26 Sep 2025 Issue date: 17 May 2022 |
Grant | Utility: Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof Filling date: 26 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Methods for the treatment of subjects having a hepatitis b virus (HBV) infection Filling date: 26 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof Filling date: 26 Sep 2025 Issue date: 3 May 2022 |
Application | Utility: KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: REVERSIR TM COMPOUNDS Filling date: 26 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: EXTRAHEPATIC DELIVERY Filling date: 26 Sep 2025 Issue date: 28 Apr 2022 |
Grant | Utility: Modified iRNA agents Filling date: 26 Sep 2025 Issue date: 26 Apr 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 21 Apr 2022 |
Grant | Utility: Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Filling date: 26 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases Filling date: 26 Sep 2025 Issue date: 29 Mar 2022 |
Application | Utility: COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: MODIFIED DOUBLE-STRANDED RNA AGENTS Filling date: 26 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES Filling date: 26 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES Filling date: 26 Sep 2025 Issue date: 13 Jan 2022 |
Application | Utility: AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENT COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: POLYNUCLEOTIDE AGENTS TARGETING AMINOLEVULINIC ACID SYNTHASE-1 (ALAS1) AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 6 Jan 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE Filling date: 26 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: POLYNUCLEOTIDE AGENTS TARGETING HYDROXYACID OXIDASE (GLYCOLATE OXIDASE, HAO1) AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: POLYNUCLEOTIDE AGENTS TARGETING PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: LACTATE DEHYDROGENASE A (LDHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 29 Jul 2021 |
Showing 1 to 40 of 40 patents.